1. The CDC has identified 28 cases of serious blood clots among the more than 8.7 million people in the U.S. who have received a Johnson & Johnson COVID-19 vaccine, a CDC official said May 12.
2. The FDA, on May 10, has authorized Pfizer’s COVID-19 vaccine to be used in children as young as 12.
3. States won’t receive any doses of Johnson & Johnson’s COVID-19 vaccine next week, four sources told Politico May 11.
4. Moderna said May 6 its COVID-19 vaccine is 96 percent effective in adolescents ages 12-17, according to an initial analysis of a phase 2/3 trial.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.